Works matching AU Diehl, Volker


Results: 125
    1
    2
    3
    4
    5
    6

    Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.

    Published in:
    Annals of Neurology, 2010, v. 67, n. 2, p. 182, doi. 10.1002/ana.21824
    By:
    • Juergens, Annika;
    • Pels, Hendrik;
    • Rogowski, Sabine;
    • Fliessbach, Klaus;
    • Glasmacher, Axel;
    • Engert, Andreas;
    • Reiser, Marcel;
    • Diehl, Volker;
    • Vogt-Schaden, Marlies;
    • Egerer, Gerlinde;
    • Schackert, Gabriele;
    • Reichmann, Heinz;
    • Kroschinsky, Frank;
    • Bode, Udo;
    • Herrlinger, Ulrich;
    • Linnebank, Michael;
    • Deckert, Martina;
    • Fimmers, Rolf;
    • Schmidt-Wolf, Ingo G. H.;
    • Schlegel, Uwe
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy.

    Published in:
    European Journal of Haematology, 2005, v. 75, p. 68, doi. 10.1111/j.1600-0609.2005.00458.x
    By:
    • Mauch, Peter;
    • Ng, Andrea;
    • Aleman, Berthe;
    • Carde, Patrice;
    • Constine, Louis;
    • Diehl, Volker;
    • Dinshaw, Ketayun;
    • Gospodarowicz, Mary;
    • Hancock, Steve;
    • Hodgson, David;
    • Hoppe, Richard;
    • Raymond Liang;
    • Loeffler, Markus;
    • Specht, Lena;
    • Travis, Lois B.;
    • Wirth, Andrew;
    • Yahalom, Joachim
    Publication type:
    Article
    33

    CT and MR imaging in Hodgkin's disease– present and future.

    Published in:
    European Journal of Haematology, 2005, v. 75, p. 83, doi. 10.1111/j.1600-0609.2005.00460.x
    By:
    • Gossmann, Axel;
    • Eich, Hans Theodor;
    • Engert, Andreas;
    • Josting, Andreas;
    • Müller, Rolf-Peter;
    • Diehl, Volker;
    • Lackner, Klaus-Jürgen
    Publication type:
    Article
    34
    35
    36

    Introduction.

    Published in:
    2004
    By:
    • Diehl, Volker;
    • Josting, Andreas;
    • Heidecke, Cordula
    Publication type:
    Other
    37
    38
    39
    40

    New treatments for Hodgkin’s disease.

    Published in:
    Current Treatment Options in Oncology, 2002, v. 3, n. 4, p. 283, doi. 10.1007/s11864-002-0028-x
    By:
    • Glossmann, Jan-Peter;
    • Josting, Andreas;
    • Diehl, Volker
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.

    Published in:
    1990
    By:
    • Hiddemann, Wolfgang;
    • Schmitz, Norbert;
    • Pfreundschuh, Michael;
    • Pflüger, Karl-Heinz;
    • Ollech-Chwoyka, Jürgen;
    • Tirier, Christian;
    • Maschmeyer, Georg;
    • Kirchner, Hartmut;
    • Wagner, Thomas;
    • Koch, Peter;
    • Dahmen, Elmar;
    • Fiedler, Walter;
    • Trümper, Lorenz;
    • Diehl, Volker;
    • Hiddemann, W;
    • Schmitz, N;
    • Pfreundschuh, M;
    • Pflüger, K H;
    • Ollech-Chwoyka, J;
    • Tirier, C
    Publication type:
    journal article
    47
    48
    49

    Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.

    Published in:
    International Journal of Cancer, 1996, v. 66, n. 4, p. 526, doi. 10.1002/(SICI)1097-0215(19960516)66:4<526::AID-IJC17>3.0.CO;2-5
    By:
    • Schnell, Roland;
    • Katouzi, Ali A.;
    • Linnartz, Christoph;
    • Schoen, Gisela;
    • Drillich, Silke;
    • Hansmann, Martin-Leo;
    • Schiefer, Daniel;
    • Barth, Stefan;
    • Zangemeister-Wittke, Uwe;
    • Stahel, Rolf A.;
    • Diehl, Volker;
    • Engert, Andreas
    Publication type:
    Article
    50

    Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human hodgkin cells in vitro and disseminated Hodgkin tumors in scid mice using high-affinity monoclonal antibodies directed against the CD30 antigen.

    Published in:
    International Journal of Cancer, 1995, v. 63, n. 2, p. 238, doi. 10.1002/ijc.2910630216
    By:
    • Schneix, Roland;
    • Linnartz, Christoph;
    • Katouzi, Ali A.;
    • Schon, Gisela;
    • Bohlen, Heribert;
    • Horn-Lohrens, Ottmar;
    • Parwaresch, Reza M.;
    • Lange, Hans;
    • Diehl, Volker;
    • Lemke, Hilmar;
    • Engert, Andreas
    Publication type:
    Article